[Adipocytes, adipokines and metabolic alterations in pulmonary fibrosis].
Adipocytes, adipokines et altérations métaboliques dans la fibrose pulmonaire.
Adipocytes
Adipokines
Fibrose pulmonaire idiopathique
Idiopathic pulmonary fibrosis
Metabolic syndrome
Syndrome métabolique
Journal
Revue des maladies respiratoires
ISSN: 1776-2588
Titre abrégé: Rev Mal Respir
Pays: France
ID NLM: 8408032
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
05
01
2023
accepted:
06
01
2023
pubmed:
6
2
2023
medline:
28
3
2023
entrez:
5
2
2023
Statut:
ppublish
Résumé
Idiopathic pulmonary fibrosis (IPF) is a fatal respiratory disease characterized by severe remodeling of the lung parenchyma, with an accumulation of activated myofibroblasts and extracellular matrix, along with aberrant cellular differentiation. Within the subpleural fibrous zones, ectopic adipocyte deposits often appear. In addition, alterations in lipid homeostasis have been associated with IPF pathophysiology. In this mini-review, we will discuss the potential involvement of the adipocyte secretome and its paracrine or endocrine-based contribution to the pathophysiology of IPF, via protein or lipid mediators in particular.
Identifiants
pubmed: 36740493
pii: S0761-8425(23)00039-6
doi: 10.1016/j.rmr.2023.01.016
pii:
doi:
Substances chimiques
Adipokines
0
Lipids
0
Types de publication
Review
English Abstract
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
225-229Informations de copyright
Copyright © 2023 SPLF. Published by Elsevier Masson SAS. All rights reserved.